Erica Browne to Pyrimidines
This is a "connection" page, showing publications Erica Browne has written about Pyrimidines.
Connection Strength
1.584
-
Acceptability of the dapivirine vaginal ring for HIV-1 prevention among women reporting engagement in transactional sex. AIDS Care. 2024 01; 36(1):80-86.
Score: 0.825
-
Higher Acceptability of the Monthly Dapivirine Ring Versus Daily Oral Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women in Sub-Saharan Africa in the REACH Trial. J Acquir Immune Defic Syndr. 2025 Dec 15; 100(5):415-424.
Score: 0.247
-
Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial. J Acquir Immune Defic Syndr. 2022 08 01; 90(4):418-424.
Score: 0.196
-
First Impressions Matter: How Initial Worries Influence Adherence to the Dapivirine Vaginal Ring. J Acquir Immune Defic Syndr. 2019 07 01; 81(3):304-310.
Score: 0.159
-
We choose: Adolescent girls and young women's choice for an HIV prevention product in a cross-over randomized clinical trial conducted in South Africa, Uganda, and Zimbabwe. PLoS One. 2024; 19(8):e0308577.
Score: 0.057
-
Correlates of Adherence to Oral and Vaginal Pre-exposure Prophylaxis (PrEP) Among Adolescent Girls and Young Women (AGYW) Participating in the MTN-034/REACH Trial. AIDS Behav. 2024 Sep; 28(9):2990-3000.
Score: 0.056
-
Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial. AIDS Behav. 2021 Aug; 25(8):2430-2440.
Score: 0.045